Effective Patient Recruitment Strategies

Venue: Hyatt Regency

Location: Princeton, New Jersey, United States

Event Date/Time: Nov 18, 2002 End Date/Time: Nov 19, 2002
Report as Spam


Those of us involved with patient recruitment know, the demand for eligible study patients is outpacing the patient availability as the number of clinical trials and patients per trial continues to increase. Due to recent events and negative media attention, patient trust is waning as they are questioning the motives of sponsors and physicians. The mission of IIR’s Effective Patient Recruitment Strategies, an interactive Conference for BioPharmaceutical Professionals is to explore the mindset of the patient and determine how to best utilize this information and develop new recruitment techniques to accelerate this lengthy process, resulting in more time and cost efficient trials. Examining these issues from the patient’s perspective sheds light on the origin of the recent negative publicity and how the industry can gain back the patient’s trust through new recruitment strategies.

The conference begins with a discussion of the strengths and shortcomings of the informed consent process. Then you will begin Part One of an Interactive Survey among potential study volunteers. This interactive study, based on information from previous patient polls and feedback from the audience, will create a series of targeted questions aimed at understanding the potential study volunteer. This collectively developed questionnaire will be posted online and potential study volunteers are invited to complete it. The afternoon of the first day is dedicated to industry experts addressing pressing issues such as:

How to use benchmarking and metrics to improve patient enrollment
Discovering and utilizing the resources within your own company to assist and expedite patient recruitment
Using a multidisciplinary approach to implement a successful Phase III-b study, a detailed case study
Gaining insight into other participant’s successful recruitment strategies through an interactive group exercise
The second day of the conference is Part Two of the Interactive Volunteer Study. This session begins with a presentation from CenterWatch on the responses to the questions from Part One. Immediately following, there is a discussion with a panel of experts about how these results should affect your recruitment strategies. This panel discussion draws conclusions from these results across different therapeutic areas, and helps you determine how to best understand the mindset of potencial study volunteers and strategize recruitment plans accordingly. Our panel of experts includes representatives involved in all stages of the recruitment process including Sponsors, CROs, and Online Service Companies. In addition, we present a session on gaining back the patient’s trust by learning how to combat the recent negative publicity surrounding human research subjects.

The afternoon of Day Two is dedicated to an exclusive postconference workshop. Attend our specially selected workshop, Successful Strategies for Pediatric Patient Recruitment and Retention, hosted by the distinguished John Niles of Pediatric Clinical Trials International.

Patient recruitment begins and ends with the study volunteer. This conference is designed to help you better understand the patient and as a result, fine-tune your recruitment strategies to make them more effective. The conference also provides networking opportunities, panel discussions, group exercises and Q&A sessions as well as a chance for you to converse amongst your colleagues to design questions to be addressed to potential patients. This conference is developed for industry professionals from Biotech and Pharmaceutical Companies, CROs, Investigative Sites, Recruitment Firms and anyone else directly involved with patient recruitment.

Our distinguished speaking faculty
includes representatives from:

Amgen, Inc., Aventis, CenterWatch, Cordis Corporation, Pediatric
Clinical Trials International, Genta Incorporated, Global Clinical
Trial Services, Johnson & Johnson, Matthews Media Group, and
PharmaTech Solutions, Inc.

Institute for International Research deeply appreciates the contribution of our reputable Advisory Board:

Jose Capellan, Clinical Research Scientist, Aventis

Kathleen Colatrella, Director of Clinical Research,
Genta Incorporated

Kathleen Drennan, Chief Global Marketing and Strategic
Business Development, Global Clinical Trial Services

John Needham, Senior Director, Global Clinical Trials, Johnson & Johnson Pharmaceutical Research and Development, LLC